Elon Musk has threatened to ban Apple iPhones from X, Tesla, and SpaceX, calling the tech giant’s deal with OpenAI a security risk, and saying that Apple has ‘no clue’ that its data might be compromised in the long run.

The Food and Drug Administration’s advisory committee endorsed Eli Lilly’s Alzheimer’s drug, donanemab, for approval to further slow the aggression of the specific type of dementia in patients despite criticisms regarding test patient deaths during clinical trials.

SARS claims that clothing stores are evading the tax hikes in South Africa. Officials explained how clothing brands are possibly doing it.

Meta said it wants to use European data for AI training while facing privacy concerns from European countries. Can it be allowed to do so?

Biotech giant Roche is accusing Indian manufacturers of counterfeiting its Accu-Chek devices. The company claims fake ones are being sold on Amazon.

The U.K. and Canada launched a joint investigation into the 23andMe data breach in 2023. But why do they want to investigate it?

US Senate demands clarification from BMW for having supply chains from blacklisted Chinese companies due to their link with Uyghur child labor camps.

Abbott Laboratories announced that new FDA-cleared continuous glucose monitor sensors are available over-the-counter without a prescription.

The FDA is examining Diamond Shruumz-brand microdosing chocolate bars after eight individuals experienced symptoms including vomiting, seizures, and central nervous system depression, prompting concerns over the product's safety.

Prime Minister Justin Trudeau's government will vote on a proposed capital-gains tax inclusion rate hike.